These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1074 related items for PubMed ID: 18280117

  • 1. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [Abstract] [Full Text] [Related]

  • 2. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
    Tré-Hardy M, Macé C, El Manssouri N, Vanderbist F, Traore H, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M, Traore H, El Manssouri N, Vanderbist F, Vaneechoutte M, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C.
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G, McKevitt M, Elborn JS, Tunney MM.
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [Abstract] [Full Text] [Related]

  • 6. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
    Halwani M, Yebio B, Suntres ZE, Alipour M, Azghani AO, Omri A.
    J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388
    [Abstract] [Full Text] [Related]

  • 7. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.
    Nagant C, Tré-Hardy M, El-Ouaaliti M, Savage P, Devleeschouwer M, Dehaye JP.
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):251-63. PubMed ID: 20625718
    [Abstract] [Full Text] [Related]

  • 8. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
    Halwani M, Hebert S, Suntres ZE, Lafrenie RM, Azghani AO, Omri A.
    Int J Pharm; 2009 May 21; 373(1-2):141-6. PubMed ID: 19429299
    [Abstract] [Full Text] [Related]

  • 9. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M, Morosini MI, Köksal E, Oliver A, Ekkelenkamp M, Cantón R.
    Antimicrob Agents Chemother; 2018 Jan 21; 62(1):. PubMed ID: 29084746
    [Abstract] [Full Text] [Related]

  • 10. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
    Treerat P, Widmer F, Middleton PG, Iredell J, George AM.
    FEMS Microbiol Lett; 2008 Aug 21; 285(1):40-50. PubMed ID: 18513356
    [Abstract] [Full Text] [Related]

  • 11. Influence of gentamicin and tobramycin on binary biofilm formation by co-cultures of Burkholderia cepacia and Pseudomonas aeruginosa.
    Al-Bakri AG, Gilbert P, Allison DG.
    J Basic Microbiol; 2005 Aug 21; 45(5):392-6. PubMed ID: 16187262
    [Abstract] [Full Text] [Related]

  • 12. Development of a rapid colorimetric time-kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa.
    Moriarty F, Elborn S, Tunney M.
    J Microbiol Methods; 2005 May 21; 61(2):171-9. PubMed ID: 15722142
    [Abstract] [Full Text] [Related]

  • 13. In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media.
    Thellin O, Zorzi W, Jolois O, Elmoualij B, Duysens G, Cahay B, Streel B, Charif M, Bastin R, Heinen E, Quatresooz P.
    Int J Antimicrob Agents; 2015 Jul 21; 46(1):33-8. PubMed ID: 25963337
    [Abstract] [Full Text] [Related]

  • 14. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
    Cai Y, Yu XH, Wang R, An MM, Liang BB.
    J Pharm Pharmacol; 2009 Sep 21; 61(9):1257-62. PubMed ID: 19703377
    [Abstract] [Full Text] [Related]

  • 15. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada.
    Beaudoin T, Aaron SD, Giesbrecht-Lewis T, Vandemheen K, Mah TF.
    Can J Microbiol; 2010 Jul 21; 56(7):548-57. PubMed ID: 20651854
    [Abstract] [Full Text] [Related]

  • 16. [Interaction between biofilm formed by Pseudomonas aeruginosa and antibacterial agents].
    Feng X, Zhao G, Cui L, Guan X, Wang H.
    Wei Sheng Wu Xue Bao; 2000 Apr 21; 40(2):210-3. PubMed ID: 12548947
    [Abstract] [Full Text] [Related]

  • 17. The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents.
    Al-Bakri AG, Othman G, Bustanji Y.
    J Appl Microbiol; 2009 Jul 21; 107(1):280-6. PubMed ID: 19302313
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model.
    Cai Y, Fan Y, Wang R, An MM, Liang BB.
    J Antimicrob Chemother; 2009 Sep 21; 64(3):563-6. PubMed ID: 19561148
    [Abstract] [Full Text] [Related]

  • 19. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
    Herrmann G, Yang L, Wu H, Song Z, Wang H, Høiby N, Ulrich M, Molin S, Riethmüller J, Döring G.
    J Infect Dis; 2010 Nov 15; 202(10):1585-92. PubMed ID: 20942647
    [Abstract] [Full Text] [Related]

  • 20. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
    Zuravleff JJ, Yu VL, Yee RB.
    J Lab Clin Med; 1983 Jun 15; 101(6):896-902. PubMed ID: 6406628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.